New Zealand markets closed

Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
1.3700-0.1000 (-6.80%)
At close: 04:00PM EST
1.3600 -0.01 (-0.73%)
After hours: 07:59PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 2.93B
Enterprise value 2.28B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.33
Price/book (mrq)2.34
Enterprise value/revenue 7.25
Enterprise value/EBITDA -3.47

Trading information

Stock price history

Beta (5Y monthly) 1.30
52-week change 3-12.50%
S&P500 52-week change 325.42%
52-week high 32.5450
52-week low 31.1200
50-day moving average 31.4322
200-day moving average 31.6616

Share statistics

Avg vol (3-month) 321.5M
Avg vol (10-day) 321.6M
Shares outstanding 51.64B
Implied shares outstanding 62.14B
Float 81.09B
% held by insiders 17.09%
% held by institutions 185.35%
Shares short (31 Jan 2024) 4236.91M
Short ratio (31 Jan 2024) 410.44
Short % of float (31 Jan 2024) 417.86%
Short % of shares outstanding (31 Jan 2024) 411.18%
Shares short (prior month 29 Dec 2023) 4235.5M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023


Profit margin -271.96%
Operating margin (ttm)-310.70%

Management effectiveness

Return on assets (ttm)-25.17%
Return on equity (ttm)-63.46%

Income statement

Revenue (ttm)314.98M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)-16.50%
Gross profit (ttm)N/A
EBITDA -709.52M
Net income avi to common (ttm)-856.64M
Diluted EPS (ttm)-0.4100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.05B
Total cash per share (mrq)0.53
Total debt (mrq)403.66M
Total debt/equity (mrq)32.22%
Current ratio (mrq)6.78
Book value per share (mrq)0.63

Cash flow statement

Operating cash flow (ttm)-342.2M
Levered free cash flow (ttm)-62.38M